Following over 100 deaths linked to the synthetic opioid nitazenes, experts criticize the UK’s slow response and inadequate measures to track and combat the spread of these lethal drugs.
The UK has come under scrutiny for its delayed response to the proliferation of a highly dangerous type of synthetic opioid known as nitazenes, following a link to over 100 deaths. Experts are concerned that the actual number of fatalities might be significantly higher due to ineffective data collection methods on non-fatal overdoses, which are essential for understanding the spread of these drugs and preventing further loss of life. Despite recent efforts to combat the issue, including the classification of fifteen synthetic opioids as Class A drugs—imposing severe penalties for their supply and production—critics argue that the UK lags in establishing a comprehensive tracking system for nitazenes-related incidents.
Nitazenes, considered to be much stronger than heroin and fentanyl, with some variants being 100 times more potent than heroin, often appear in white powder or crystallized forms. They have been linked to severe health risks, including reduced breathing, nausea, lowered heart rate, and potentially fatal overdoses. These substances are often mislabeled and mixed with other drugs, making it difficult for users to know what they are consuming. The National Crime Agency has identified illicit labs in China as a primary source of nitazenes, which enter the UK through various channels, including being mixed with heroin by organised crime groups.
The government’s recent actions to address the crisis include enhanced surveillance and early-warning systems, alongside efforts to restrict the availability of these lethal drugs. However, healthcare professionals like Dr. Mark Pucci have pointed out the lack of adequate testing facilities within the NHS to accurately determine the scale of nitazene use and its consequences. There are calls for a more coordinated national strategy to deal with the emerging threat of synthetic opioids, emphasizing the need for better data collection on non-fatal overdoses to prevent further deaths.
